Andrew Aromando, Chief Officer of Oncolytics Biotech ONCY, has filed 1 purchase and 0 sales on the open market. Over the past 12 months that comes to a net purchase of $25.5K. The latest trade was on 06/01.

AA

AA

Andrew Aromando

Chief Business Officer

Company

Oncolytics Biotech ONCY

First filing

23/05/05

Trades

8 trades

Buys / sales

1 / 0

12-month net buying

$25.5K

Last trade

06/01

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Oncolytics BiotechONCY	Open-market buy	02/11	02/13	29,600 sh	$0.86	$25,456	+116.1%